INTRODUCTION
Chondroadherin is a non-collagenous extracellular matrix protein which was first isolated and purified from bovine cartilage [1] . The determination of the primary structure of the protein identified it as a member of the leucine-rich repeat (LRR) family of proteins [2, 3] . Chondroadherin has been shown to promote attachment of chondrocytes and fibroblasts efficiently [4] , mediated via the integrin α # β " [5] . More recently, a preparation of the protein from bovine bone was reported to promote attachment of osteoblasts [6] . Further clues as to the function of the protein are now presented in studies of the expression of the protein during tissue differentiation and remodelling.
As a model to study the expression of cartilage macromolecules in a dynamic situation with marked tissue changes, we have utilized the normal, postnatal development of the rat femoral head, which includes the formation of a secondary ossification centre and an articular cartilage [7, 8] . The growth cartilage is characterized by distinct tissue compartments with cells showing different activities, the resting, proliferative, hypertrophic and calcified zones [9] . The hypertrophy of the chondrocytes and initiation of calcification occur in the secondary ossification centre of the rat femoral head at discrete time points, i.e. at 18 and 21 days post partum, respectively [8, 10] . At the same time the superficial parts develop into a functional articular cartilage and remain uncalcified. Why some parts of primary cartilageskeleton become calcified and develop into bone while others remain non-calcified is not known, but the process must be tightly regulated at the molecular level. Thus, a number of noncollagenous cartilage matrix proteins are likely to have different roles in the endochondral ossification process [11] . In accordance, it has been shown that the abundance of several matrix constituents changes during the calcification process as shown in Abbreviations used : COMP, cartilage oligomeric matrix protein ; ECM, extracellular matrix ; GAG, glycosaminoglycan ; GAPDH, glyceraldehyde 3-phosphate dehydrogenase ; LRR, leucine rich repeat ; PTHrP, parathyroid hormone related protein ; RT-PCR, reverse-transcriptase PCR ; SSC, sodium chloride and sodium citrate ; SSPE, sodium chloride, sodium phosphate, and EDTA ; DAB, diaminobenzidine tetrahydrochloride.
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chondroadherin was seen in the territorial matrix around late proliferative cells in the growth plate as well as in the developing articular cartilage in the maturing femoral head. Localization of chondroadherin mRNA by in situ hybridization was in agreement with immunocytochemistry with strong hybridization signals in late proliferative cells in the growth plate. In the articular cartilage the expression was restricted to cells in the lower regions. A three-fold increase of cartilage chondroadherin content in the growing femoral head was demonstrated by Western blot analysis. The high expression of this cell binding protein in a dynamic region of cartilage suggests an important role for chondroadherin in the regulation of chondrocyte growth and proliferation.
studies of extractable macromolecules such as the highly negatively charged proteoglycans [7] and cartilage oligomeric matrix protein (COMP) [8] .
In the present study we determined the primary structure of rat chondroadherin. Expression of chondroadherin mRNA in various rat tissues was studied by Northern blot analysis and reversetranscriptase PCR (RT-PCR) as well as by in situ hybridization. In parallel, the localization of the chondroadherin protein was investigated by immunostaining of the maturing femoral head of Wistar rats from day 14 to day 60. The findings from histology were corroborated in studies of altered quantities of the protein in the maturing femoral head.
MATERIALS AND METHODS

Cloning and sequence analysis of cDNA
A rat chondrosarcoma cDNA library [12] was screened with a cDNA probe from a bovine chondroadherin clone [2] . The cDNA sizes were estimated by electrophoresis on a 1 % (w\v) agarose gel after digestion with restriction enzyme EcoRI. A full length, 1n6 kbp clone was isolated and purified with a Plasmid Midi Kit (QIAGEN. Inc.). DNA sequencing was performed in full on both strands by standard double-strand dideoxy termination sequencing using T3, T7 and synthetic internal specific primers.
Analysis of RNA
Total RNA from various rat tissues and rat chondrosarcoma cells was prepared by single-step RNA isolation according to Chomczynski and Sacchi [13] . 10 µg of total RNA from various rat tissues were separated on 1 % agarose\2n2 M formaldehyde gel and transferred to a nylon membrane (Hybond4-N, Amersham) by capillary transfer. Probes were labelled with a [$#P]dCTP by using a random primed DNA labelling kit (Boehringer Mannheim, Germany). After ultraviolet light crosslinking the filter was prehybridized with a prehybridization solution (5iSSPE, 5iDenhardt's solution, 0n2 % SDS, 10 % dextran sulphate, 50 % formamide and 0n1 % denatured salmon sperm DNA) for 2 h, then the $#P-labelled cDNA probe was added to the prehybridization solution at 10' c.p.m.\ml and incubated at 42 mC overnight. The filters were washed twice with 2iSSPE containing 0n1 % SDS and with 1iSSPE, followed by final washing once with 0n1iSSPE, at 42 mC for 15 min. The filter was exposed to Cronex2 4 medical X-ray film (DuPont, U.S.A.) at k70 mC overnight and developed.
cDNA synthesis and RT-PCR
Total RNA used for synthesis of cDNA from various rat tissues and rat chondrosarcoma cells was prepared as mentioned above. Samples were reverse transcribed into single stranded cDNA by using Superscript4II (Gibco BRL, Life Technologies) according to the manufacturer's instructions. Immediately before cDNA synthesis the RNA samples were heated to 70 mC for 10 min with oligo(dT) primer and quickly cooled on ice. Then first strand buffer, dithiothreitol, dNTP mixture and Superscript4II were added. Samples were incubated, first at 42 mC for 50 min and then at 70 mC for 15 min. The cDNAs were amplified using 1 µM of a 21-mer upstream primer I (CGCTGGCTCTACCTGT-CAGAA), located at position 568 and 1 µM of a 20-mer downstream primer II (GACCTCTTGGTGGGGGATTT), located at position 1087 of the cDNA sequence (see Figure 1) . Amplification of cDNA was carried out in a thermocycler using Taq DNA polymerase and buffer supplied with the enzyme (Gibco BRL, Life Technologies) at 1 mM MgCl # . The PCR was initiated by a hot start followed by 30 cycles at 94 mC, for 30 s ; 58 mC, for 30 s ; 72 mC, for 2 min. 2 % of the products from the first amplification were re-amplified with a pair of nested primers : 1 µM of a 21-mer upstream primer III (CTTTGGCAGATACC-TGGAGAC), located at position 771 and 1 µM of a 20-mer downstream primer IV (CTTGAACTTGGCTGGTGAAG), located at position at 1028 of cDNA sequence (see Figure 1) . The PCR was performed as above by 25 cycles at 94 mC, for 30 s ; 62 mC, for 30 s ; 72 mC, for 2 min. The identity of the PCR products was verified by sizing 10 % of the products by 1n5 % agarose gel electrophoresis and by digestion with restriction enzyme AflIII (Boehringer Mannheim, Germany), which cleaves at a unique site at position 861 of the nucleotide sequence.
Control PCR amplification was performed with a pair of 21-mer primers designed from rat collagen αI (position 970 and 1459) to verify that chondroadherin negative samples contained intact, amplifiable cDNA. All samples contained amplifiable collagen cDNA (data not shown).
Analysis of protein
Whole femoral heads, from each age studied, were homogenized by the use of a Polytron and extracted overnight at 4 mC with 10 ml of 4 M guanidinium chloride, 0n1 M ε-aminocaproic acid, 5 mM benzamidine hydrochloride, 0n05 M sodium acetate and 5 mM N-ethylmaleimide, pH 5n8, containing 10 mM EDTA per g of tissue. Macromolecules in extracts were precipitated with 10 volumes of 95 % ethanol containing 50 mM sodium acetate, washed once with 70 % ethanol and finally dissolved in non-reducing electrophoresis reagent. Samples from each age group corresponding to 2, 1 and 0n5 mg tissue respectively were separated on SDS 4-16 % polyacrylamide gel and proteins were transferred to a nitrocellulose membrane [14] . The membrane was blocked with 3 % dried milk and incubated with the same antiserum as used in immunocytochemistry (1 : 500 dilution in 0n01 Tris buffer, pH 7n4). Bound antibodies were detected after incubation with secondary antibodies conjugated with horseradish peroxidase by chemiluminescence using the ECL system (Amersham, Life Science). Bands corresponding to 1 mg tissue samples were chosen for semiquantitative analyses since the density of these bands were within the linear range of the film sensitivity. The bands detected were quantified by scanning densitometry with the Gel-Pro Analyser program (Ver. 2.0, Media Cybernetics, MD, U.S.A.).
Quantification of glycosaminoglycan
The same extracts as used for quantification of chondroadherin were directly precipitated with Alcian Blue for glycosaminoglycan quantification [15] .
Preparation of tissue sections
Femoral heads from rats of the Wistar strain aged 14-60 days were used in the present study. The femoral heads were dissected free from surrounding tissues, immediately frozen in liquid nitrogen and embedded in Tissue-Tek O.C.T. compound (Miles Scientific Co., Naperville, IL, U.S.A.). Embedded tissues were cut into 6 µm sections in a cryostat at k25 mC. Sections were mounted on gelatin-coated glass coverslips. Toluidine Blue and von Kossa's staining were used to provide a general background and discern calcification as previously described [8, 16] .
Immunocytochemistry
For immunocytochemistry, an antiserum recognizing a C-terminal peptide (KRSKKAGRH) of rat\bovine chondroadherin raised in rabbits was used. This antiserum has been shown to react with chondroadherin only in crude cartilage extracts. An antiserum against pig collagen X was a kind gift from Dr Rucklidge, Aberdeen, U.K. The ABC avidin-biotin-peroxidase complex method was used for staining as previously described [8] . Sections for immunocytochemistry were air-dried at room temperature, fixed in acetone, then stored at k20 mC until stained. After rinsing with PBS the sections were pre-treated with 0n5 % hydrogen peroxide at room temperature for 20 min to inhibit endogenous peroxidase. Subsequently digestion with chondroitinase ABC (Sigma), 40 munits\ml in 0n05 M Tris, 0n15 M sodium chloride containing 0n1 % (w\v) BSA, pH 7n4, was used to increase penetration of antibodies. Sections were treated with 1n5 % (v\v) normal goat serum for 30 min at room temperature prior to incubation with primary antisera. Excess serum was gently blotted off and the sections were incubated with primary antiserum (1 : 500 in PBS containing 0n25 % BSA) at 4 mC overnight. After thorough rinsing the sections were consecutively incubated with an affinity-purified, biotinylated goat anti-rabbit immunoglobulin antibody (1 : 200 in PBS), and with avidin-biotin-peroxidase complex for 30 min, at room temperature. After rinsing the sections were developed with freshly prepared 0n06 % diaminobenzidine tetrahydrochloride (DAB) and finally sealed with Permount (Fisher Scientific Company, Fair Lawn, NJ, U.S.A.). They were observed and photographed with a Nikon Microphot-FAX microscope. Sections were also stained omitting pre-treatment with enzyme. Chondroadherin in rat tissues A potential signal peptide cleavage site is indicated by an arrow. Underlined is the C-terminal peptide used to generate the rabbit antiserum used in this study.
For immunostaining with antiserum against collagen X, sections were demineralized with EDTA as previously described [8] , and then pre-digested with chondroitinase ABC as above plus hyaluronidase (Sigma, 1 mg\ml) followed by staining with antiserum (1 : 200 in PBS) containing 0n25 % BSA as mentioned above. Other sections were stained without treatment with EDTA. Routine control experiments for checking antiserum performance were done by replacing the specific antibody with preimmune serum or antiserum dilution buffer.
In situ hybridization
For in situ hybridization, a 50-mer rat oligonucleotide probe corresponding to nucleotides 421-372 of rat chondroadherin cDNA was used. The sequence of this chondroadherin antisense probe was 5h-GGTCAGTCAGGTCATCGAAGGCTCCAGC-TCGCAGCACCCGGATGTCATTG-3h. The probe was labelled with [α-$&S]dATP (Amersham, Solna, Sweden) using terminal deoxynucleotidyl transferase (Gibco BRL, Life Technologies) as previously described [8] . Negative control sections were obtained by treatment with RNase A prior to hybridization. Initially, antisense and sense RNA probes, covering base 240-430, were tested giving a hybridization pattern in cartilage essentially identical to the results presented with the oligonucleotide probe. However, unacceptably high background was obtained with the RNA probes in calcified regions precluding their further use.
The hybridization solution contained 50 % (v\v) deionized formamide, 10 % w\v) dextran sulphate, 1iDenhardt's solution (0n02 %, w\v, each of BSA, Ficoll and polyvinylpyrrolidone), 4iSSC (sodium chloride and sodium citrate), denatured salmon sperm DNA (0n5 µg\µl) and yeast tRNA (0n25 µg\µl), 1 % (w\v) sodium N-lauroylsarcosinate and 20 000 c.p.m. of $&S-labelled oligonucleotide probe per µl. Dithiothreitol was added to 0n1 M to the hybridization solution directly prior to use.
Sections were directly stored in RNase-free boxes at k70 mC. The hybridization procedures used were similar to those used in a previous study [8] with minor modifications of the concentrations of probes and washing solution (SSC), as well as washing temperature. Briefly, slides were removed from the freezer, thawed and dried with a hair dryer. Slides were then post-fixed in 4 % (w\v) freshly prepared paraformaldehyde in PBS, acetylated with 0n25 % (v\v) acetic anhydride in 0n1 M triethanolamine buffer, and finally dehydrated in increasing concentrations of ethanol. Each section was hybridized with 10' c.p.m. of labelled antisense oligonucleotide probe in a humid chamber at 37 mC overnight. After hybridization, the sections were washed in 2iSSC at 50 mC and then dehydrated in an ascending series of ethanol containing 0n3 M ammonium acetate. After dipping in Ilford K-5 photographic emulsion (Ilford, England), the sections were stored with desiccant at 4 mC for 2-3 weeks. The photoemulsion was developed, fixed and sections were counterstained with haematoxylin and finally mounted in Kaiser's medium (glycerol\gelatin ; Merck, Darmstadt, Germany). The slides were examined and photographed with both bright-and dark-field illumination.
RESULTS
Sequence of rat chondroadherin
The rat chondrosarcoma cDNA clone of 1651 bp (Figure 1 ) appears to encode the full length sequence of rat chondroadherin since the size of the cDNA correspond to the size of the mRNA, see below. No classical AATAAA polyadenylation signal is present making the assignment of the 3h end uncertain. However, a potential alternative polyadenylation signal is an ATAAAC-ATAAA sequence beginning 20 bases upstream of the 3h poly(A) stretch. The length of the 5h-untranslated region is similar to the length of the same region in bovine chondroadherin cDNA. Thus the rat clone most likely represents a full length cDNA. The translated sequence for rat chondroadherin is highly similar to bovine chondroadherin with 93 % identity at the amino acid level. The C-terminal region chosen for generation of the polyclonal rabbit antiserum is completely conserved.
Tissue distribution of rat chondroadherin RNA
Northern blot analysis was performed on total RNA prepared from various rat tissues and freshly isolated rat chondrosarcoma cells (Figure 2) . A 1n6 kb chondroadherin mRNA was detected in the whole femoral head and rib cartilage preparations. A weak signal was also detected in the chondrosarcoma RNA preparation. Surprisingly, a strong hybridization signal for chondroadherin mRNA was found in rat tail tendon RNA preparations (Figure 2a ). The quality and amounts of the isolated RNA was confirmed by hybridization with a rat glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA probe (Figure 2b) or by staining the separation gel with ethidium bromide (Figure 2c) .
The results from Northern blot analysis were confirmed and further extended by using RT-PCR analysis. cDNAs from various tissues were amplified in a two-step procedure with nested primers. Agarose gel electrophoresis showed a predicted product with a size of about 277 bp in femoral head, rib cartilage, chondrosarcoma cells and tendon, but also in calvaria, bone and bone marrow RNA preparations (Figure 3 ). The identity of the PCR products was confirmed by digestion with the restriction enzyme Afl III and agarose electrophoresis (data not shown).
Routine histology
Routine histological examinations were carried out at different stages of endochondral bone formation and articular cartilage differentiation in the rat femoral head. Changes in chondrocyte morphology typical for hypertrophy on day 18 in the secondary ossification centre and appearance of mineralization on day 21 as well as ossification around day 45 were similar to those described previously [8, 10] .
Localization and expression of chondroadherin during femoral head maturation
An anti-peptide antiserum raised against the C-terminal amino acids of rat\bovine chondroadherin was used for immunocytochemistry. The anti-peptide antiserum is highly specific and recognizes only chondroadherin on protein blots of crude cartilage extracts (see Figure 6 below). Another polyclonal rabbit antiserum raised against isolated bovine chondroadherin, which works well in ELISA assays on bovine tissue extracts [1] , did not stain rat tissue sections. Immunocytochemistry with rat femoral heads of different ages showed a general distribution of chondroadherin to all cartilaginous regions. The strongest immunoreactivity was at all ages detected in the growth cartilage region ( Figures 4A, 4C, 4E and 5A) .
At the youngest age examined, day 14, chondroadherin was readily detectable in the cartilage, with clear staining in the growth plate, but with little more than background staining in the bulk of the cartilage ( Figure 4A ). The more superficial parts of the femoral head corresponding to the developing articular cartilage layer, however, showed some weak immunostaining ( Figure 4A ). At this stage, mRNA for chondroadherin was only detected by the use of in situ hybridization at the lower level in growth cartilage region ( Figure 4B ). No mRNA was detected in the underlying bone trabeculae.
At the time of onset of calcification, day 20, the staining for chondroadherin decreased somewhat in the centre portion of the femoral head when the cells had entered hypertrophy ( Figure  4C ). At this stage a larger number of chondrocytes in the primary cartilage growth zone expressed detectable levels of chondroadherin mRNA ( Figure 4D ). Only low expression of chondroadherin mRNA was seen at other sites. With increasing age, the area of mineralization expanded and concomitantly the presence of chondroadherin at this tissue compartment decreased ( Figure 4C and 4E) . At day 33, chondroadherin was abundant in a narrow zone in the growth cartilage region as well as in the region corresponding to the developing articular cartilage ( Figure  4E ). At this stage chondroadherin mRNA levels appeared to be substantially increased in both the growth cartilage region and in forming articular cartilage as seen by in situ hybridization ( Figure  4F ), consistent with results from immunostaining. There was neither detectable immunostaining nor hybridization for mRNA in the now calcified secondary ossification zone.
The intensity of chondroadherin staining in the articular cartilage increased further at day 60, both with regard to immunostaining and in situ hybridization ( Figure 5A and 5D) , and remained very intense in a narrow zone of the primary growth cartilage region. Chondroadherin is mainly present in the territorial matrix of the deeper parts of the articular cartilage but there is some weaker staining in the interterritorial matrix ( Figure  5B ). This corresponds to sites with marked hybridization for chondroadherin mRNA ( Figure 5D and 5E). Abundant protein was seen in the growth cartilage plate around the lower region of proliferative chondrocytes ( Figure 5A and 5C). Moreover, strong mRNA hybridization signals were detected in the late proliferative chondrocytes above the hypertrophic chondrocytes in the primary growth cartilage region ( Figure 5F ).
Immunostaining for collagen X was used as a reference for hypertrophic chondrocytes and showed localization below the zone of most intense chondroadherin staining. Collagen X was localized interterritorially in the lower part of the cartilage growth region with staining extending into cartilage spiculae between the bone trabeculae ( Figure 5G and 5I) . Collagen X was also detectable in the secondary ossification centre in a region close to articular cartilage ( Figure 5H ). In general, sections not pre-digested with enzymes showed a similar but weaker staining pattern. The controls for antibody specificity, with the preimmune rabbit serum, showed no immunostaining either in cartilage or in bone ( Figure 4G ). There were no detectable hybridization signals in control sections for in situ hybridization after pretreatment with RNase ( Figure 4H ).
Chondroadherin and glycosaminoglycan tissue content
To confirm that there was an actual increase in chondroadherin protein content during femoral head development as indicated by immunostaining and in situ hybridization, we performed semiquantitative determination of the molecule in extracts of whole femoral heads ( Figure 6 and Table 1 ). Only one major band corresponding to the expected size of about 36 kDa was
Figure 4 Sections of day 14 (A and B), day 20 (C and D) and day 33 (E to H) rat femoral heads : immunostaining for chondroadherin (bright-field illumination) and in situ hybridization with the 35 S-labelled chondroadherin oligonucleotide probe (dark-field illumination)
(A) Section stained with antiserum against chondroadherin showing moderate staining in the cartilage growth region and very weak staining in the rest of the immature femoral head cartilage. 
Figure 6 Western blot analysis of whole femoral heads of various ages
Samples of extracts of whole femoral heads corresponding to 1 mg of tissue were separated on SDS/4-16 % PAGE gel and transferred to nitrocellulose membrane for immunoblotting. Chondroadherin was detected by chemiluminescent detection with the same antiserum as used for immunocytochemistry. Lanes : (1) day 14 ; (2) day 20 ; (3) day 33, and (4) day 60.
Table 1 Analyses of growth and glycosaminoglycan contents in femoral heads of various ages
Whole femoral heads from the various ages were extracted and processed as described in the methods section. Chondroadherin (CHAD) content was quantitated by densitometry of immunoblots of samples corresponding to 1 mg tissue wet weight. Values are given as arbitrary unit density. Glycosaminoglycan (GAG) content in extracts was determined by Alcian Blue precipitation. The data are expressed in relation to wet weight and per femoral head. The ratio of CHAD/GAG gives an estimate of the relative increase of chondroadherin in cartilage. N, number of femoral heads used ; FH, femoral head ; CHAD, chondroadherin ; GAG, glycosaminoglycan. detected in extracts by Western blot analysis with the antipeptide antisera, indicating the high specificity of the antiserum. Interestingly, from day 20 a minor band appeared with a size of about 25 kDa. This most likely represents a C-terminal domain degradation fragment of chondroadherin. The bands detected were quantified by scanning densitometry and data showed that the total amount of the protein in the femoral head increased with growth of rats, especially from day 20 to day 33. The content of chondroadherin per femoral head increased approx. eight-fold from 609 (density\femoral head) to 5126 ( 
DISCUSSION
Chondroadherin is expressed by cartilaginous cells. This is supported by immunocytochemistry which shows that the protein is laid down where it is synthesized. The low level of mRNA, detected by RT-PCR in long bone and calvaria is interesting, and confirms previous reports that the protein is detected in bovine bone extracts by immunological methods [1, 6] . This restricted tissue distribution for chondroadherin is unusual among LRR proteins of the ECM. Most of the LRR-containing proteoglycans show wide tissue distribution. Biglycan, decorin, fibromodulin and lumican are all expressed in a number of connective tissues [12, 17, 18] . In tendon, expression of mRNA for chondroadherin was detected by both Northern blot and RT-PCR, while the protein was not detected by immunostaining. Apparently the level of the protein is too low to be detectable by the antibodies in the rat tendon section. Another prominent cartilage protein, COMP, is also found in tendon [19] . It is particularly interesting that the two tissues have a number of proteins in common, also including collagen II and aggrecan [20] . Indeed, tendon contains fibrocartilaginous parts, where compression due to pressure from, e.g., bone creates a load situation similar to that in cartilage.
Chondroadherin mRNA was detected in bone marrow cells by RT-PCR. Support was obtained by in situ hybridization, in initial experiments using RNA probes, showing that some bone marrow cells express chondroadherin (data not shown). The character of these bone marrow cells could not be established from the in situ hybridization.
The change in chondroadherin localization and expression upon maturation of the femoral head is very pronounced. Similarly, collagen II expression is low in immature cartilage and increases upon maturation [21] . The rather restricted distribution of chondroadherin to the lower part of the proliferative zone is intriguing, suggesting a role in regulating cell division, particularly considering the apparent absence of cell spreading and growth of chondrocytes on chondroadherin coated surfaces [4] .
Another protein showing a similar distribution of expression is Indian hedgehog, which is upstream in the signalling pathway of parathyroid hormone related protein (PTHrP), a factor apparently preventing the change to the hypertrophic phenotype of chondrocytes [22] . Whether the expression of chondroadherin is influenced by these factors is not known. To our knowledge no other extracellular matrix molecule studied thus far has shown a corresponding distinct localization around a portion of the proliferative chondrocytes of the cartilage growth plate. This very distinct localization indicates a major change in the properties of the territorial matrix immediately surrounding the cells.
No apparent immunoreactivity was seen in diaphyseal bone trabeculae, although mRNA expression was detected in bone by RT-PCR. In contrast remnants containing COMP persisted after calcification of the matrix [8] . It appears that chondroadherin is highly expressed by late proliferative chondrocytes and that it is efficiently cleared from the cartilage upon calcification and ossification.
An interesting finding is the cleavage fragment of about 25 kDa in samples of growth cartilage from day 20 to day 60. This is consistent with the elimination of chondroadherin from the tissue, when cells undergo hypertrophy. The size of the fragment recognized by the antiserum reacting with the Cterminal part of the molecule, indicates a major cleavage site in the central region of chondroadherin. The mechanisms and the regulation of this cleavage need to be elucidated. Chondroadherin is a member of the LRR protein family. A number of these proteins have been shown to interact with matrix constituents like collagens [23] [24] [25] . While chondroadherin has been shown to bind the integrin α # β " on cells [5] , thereby potentially mediating attachment and\or cell signalling, it is not clear whether the protein can bind to other matrix constituents. To further elucidate the functions of chondroadherin, its interactions will have to be further studied. Current data suggest a role in regulating cell growth and migration.
